48
Views
5
CrossRef citations to date
0
Altmetric
Original

AN EXPLORATORY STUDY OF BUPRENORPHINE USE IN BANGLADESH: A NOTE

&
Pages 1071-1083 | Published online: 03 Jul 2009

REFERENCES

  • Compton P., Ling W., Chruvastra C., Wesson D., Klett C. J. What dose of buprenorphine reduces opiate use? A double-blind dose-ranging study. In Problems of Drug Dependence, 1994; Proceedings of the 56th Annual Scientific Meeting, The College on Problems of Drug Dependence, L. Harris. National Institute on Drug Abuse, Rockville, MD 1995; II: 165
  • O'Connor P. G., Oliveto A. H., Shi J. M., Triffleman E. G., Carroll K. M., Kosten T. R., Rounsaville B. J., Pakes J. A., Schottenfeld R. S. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am. J. Med. 1998; 105(2)100–105
  • Ling W., Charuvastra C., Collins J. F., Batki S., Brown L. S.J., Kinta Udi P., Wesson D. R., McNicholas L., Tusel D. J., Malkerneker U., et al. Buprenorphine maintenance treatment of opiate dependence a multicenter, randomized clinical trial. Addiction 1998; 93(4)475–486
  • Hawks R., Chiang C. N. Buprenorphine–Naloxone combination drug for the treatment of drug addiction. In Problems of Drug Dependence, 1994; Proceedings of the 56th Annual Scientific Meeting, The College on Problems of Drug Dependence, L. Harris. National Institute on Drug Abuse, 1995; II: 165
  • Greenstein A., Fudala P. J., O'Brien C. P. Alternative pharmacotherapies for opiate addiction. Substance Abuse: A Comprehensive Textbook, J. H. Lowinson, P. Ruiz, R. B. Millman, J. G. Langrod. Williams & Wilkins, Baltimore 1992; 562–573
  • Jasinski D. R., Pevnick J. S., Griffith J. D. Human pharmacology and abuser potential of the analgesic buprenorphine. Arch. Gen. Psychiatry 1978; 35: 501–516
  • Jaffe J. Opiates clinical aspects. Substance Abuse A Comprehensive Textbook, J. H. Lowinson, P. Ruiz, R. B. Millman, J. G. Langrod. Williams & Wilkins, Baltimore 1992; 186–194
  • Alling F. A., Johnson B. D., Elmoghazy E. Cranial electro stimulation (CES) use in the detoxification of opiate dependent patients. J. Subst. Abuse. Treat 1990; 173–180
  • Kosten T. R., Krystal J. H., Charney D. S., Price L. H., Morgan C. H., Kleber H. D. Rapid detoxification from opioid dependence [Letter]. Am. J. Psychiatry 1989; 146(10)1349
  • Johnson R. E., Cone E. J., Henningfield J. E., Fudala P. J. Use of buprenorphine in the treatment of opiate addiction. I. Physiologic and behavioral effects during a rapid dose induction. Clin. Pharmacol. Ther. 1989; 46: 335–343
  • Bickel W. K., Stitzer M. L., Bigelow G. E., Liebson I. A., Jasinski D. R., Johnson R. E. A clinical trial with buprenorphine Comparison with methadone in the detoxification of heroin addicts. Clin. Pharmacol Ther. 1988; 43: 72–78
  • Quigley A. J., Bredemeyer D. E., Seow S. S. A case of buprenorphine abuse. Med. J. Aust. 1984; 140: 425–426
  • Centre for Drug Research, Universiti Sains Malaysia. An analysis of drug abuse patterns and trends of selected South Asian Cities. Proceedings of Asian Multicity Epidemiology Workgroup 1994, V. Navaratnam, F. Kin, T. B. Leng. International Monograph Series No. 6., Universiti Sain Malaysia, Penang 1995; 178–223
  • Rainey H. B. Abuse of buprenorphine. N.Z. Med. J. 1986; 99: 72
  • Hammersley R., Lavelle T., Forsyth A. Buprenorphine and temazepam abuse. Br. J. Addict. 1990; 85: 301–303
  • Ahmed S. K., Begum K. Patterns and trends of drug abuse in Dhaka, Bangladesh. Proceedings of Asian Multicity Epidemiology Workgroup 1994, V. Navaratnam, F. Kin, T. B. Leng. International Monograph Series No. 6., Universiti Sain Malaysia, Penang 1995; 11–26
  • Kumar M. S. A study of buprenorphine abuse in Madras city, India. Exploratory Studies on Drug Abuse in the Asian Region 1996, V. Navaratnam, V. Devi. International Monograph Series No. 10., Universiti Sains Malaysia, Penang 1997; 49–69
  • Bangladesh Bureau of Statistics. Wage rates. Statistical YearBook. Ministy of Planning (Statistical Division), Dhaka 1995; 63

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.